This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Europe Platelet Rich Plasma (PRP) Market

Market Insights on Europe Platelet Rich Plasma (PRP) covering sales outlook, demand forecast & up-to-date key trends

Europe Platelet Rich Plasma (PRP) Market by Product Type (Instruments, Kits, Kits BY Origin), Application (Knee, Elbow, Foot and Ankle, Shoulder, CMF, Others) & Countries Covered - Forecast to 2016-2026

Introduction

Platelet rich plasma (PRP) is a blood plasma concentrate enriched with platelet count above the baseline of whole blood prepared from patient’s own blood or from a healthy donor’s blood. There are different types of PRP, categorised on the basis of source of blood and end-product type.

Autologous PRP is a cost-effective, quick, and easy production method involving lower threat of disease transfusion as it is prepared from patient’s own blood, thus leading to its widespread adoption. Autologous PRP has been increasingly used in treatment of musculoskeletal injuries, especially in the treatment of sports-related injuries.

Allogenic PRP is prepared using blood from well-characterised donors. Allogeneic PRP helps generate more consistent and reliable therapeutic effect and also helps avoid taking large quantities of blood from patient.

Homologous platelet rich plasma is a concentrated form of blood derived from blood relatives.

Customize this Report

Let us know your requirement to get
100% FREE customization

Drivers and Trends

The Europe PRP market was valued at US$ 35.3 Mn in 2015, and is projected to grow at a CAGR of 6.6% over the forecast period 2016-2024 owing to rising demand for PRP therapy in sport injuries.

Platelet-rich Plasma (PRP) therapy is a minimally invasive procedure and an alternative option to surgery. PRP therapy is a quick and highly effective treatment for reducing the pain and enhances tissue regeneration power with less recovery time along with higher success rates. PRP treatment is very cost effective compared to surgical procedures for orthopedic and sports injuries.

Some major factors driving the growth of PRP market are expanding PRP application in the sports medicine industry, technological advancements in PRP therapy, progressive demographic ageing of the older population etc. These factors are expected to fuel the growth of the market growth rate over the forecast period.

Analysis by Country

By country, the Europe PRP market has been segmented into Germany, France, Italy, Spain, the U.K., and Rest of Europe. The U.K. PRP market has been estimated to hold maximum share in Europe region in 2016 and expected to grow at a CAGR of 8.0% over the forecast period. France is the second largest market for PRP in Europe, followed by Rest of Europe.

Europe Platelet Rich Plasma (PRP) Market Download Report Brochure

Analysis by Product Type

The European PRP market is segmented into instruments and kits segment. The kit product type segment is further sub-segmented into P-PRP kits, L-PRP kits, L-PRF kits and P-PRF kits based on end PRP product type. The kits segment also sub-segmented into autologous - PRP kits, homologous - PRP kits, and allogeneic - PRP kits based on the source of blood. Currently, the kits segment accounts for a major share of the Europe PRP market, whereas the P-PRF kits sub-segment is expected to witness an impressive growth during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Analysis by Application

By application, the Europe PRP market is segmented into knee, elbow, foot and ankle, shoulder, CMF and others. The elbow application segment is expected to grow at a CAGR of 7.4% in terms of revenues over the forecast period. The knee segment was estimated to dominate the overall European PRP market and expected to grow at a healthy CAGR over the forecast period.

Competitive Landscape

Some of the key players identified in the European PRP market report include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd, Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., and Regen Lab S.A. The report offers invaluable insights into company-specific strategies related to PRP market, market consolidation initiatives and analyses of the various market players’ specific strengths, weaknesses, opportunities and threats. Companies are focusing on developing innovative products in order to remain competitive in the Europe PRP market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segments Covered

Product Type

  • Instruments
  • Kits
    • Kits BY Type
      • Pure Platelet-Rich Plasma (P-PRP)
      • Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
      • Leukocyte-Platelet-Rich Fibrin (L-PRF)
      • Pure Platelet-Rich Fibrin (P-PRF)
  • Kits BY Origin
    • Autologous Platelet-Rich Plasma
    • Homologus Platelet-Rich Plasma
    • Allogeneic Platelet-Rich Plasma

By Application

  • Knee
  • Elbow
  • Foot and Ankle
  • Shoulder
  • CMF
  • Others

Key Countries Covered

  • Europe
  • The U.K.
  • France
  • Germany
  • Spain
  • Italy
  • Rest of Europe

Frequently Asked Questions

The Europe platelet rich plasma market is likely to secure a CAGR of 7% through 2032.

The Europe platelet rich plasma market size is estimated to cross US$ 84.10 Mn by 2032.

The Europe platelet rich plasma market is likely to record a value of US$ 42.75 Mn in 2022.

The UK is likely to lead the Europe platelet rich plasma market.

Table of Content

1.Research Methodology

2.Assumptions & Acronyms Used

3.Executive Summary

4.Platelet Rich Plasma Market overview

4.1.Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%)

4.2.Principle Growth Factors in PRP

5.Europe Platelet Rich Plasma Market Definitions

6.Platelet Rich Plasma Market : PEST Analysis and Key Regulations 

7.Europe Platelet-rich Plasma Market Dynamics

7.1.Drivers

7.2.Restraints

7.3.Opportunities

7.4.Trends

8.Europe Platelet-rich Plasma (PRP) Market Revenue, by Product Type, 2013–2024

8.1.Introduction

8.1.1. Europe PRP Market Value Share & BPS Analysis, by Product Type, 2014 & 2024

8.1.2. Europe PRP Market Y-o-Y Growth Comparison, by Product Type, 2013–2024

8.2.Market Value Forecast, By Product Type

8.2.1. Instruments

8.2.1.1.Y-o-Y Growth Comparison

8.2.1.2.Market Value Forecast

8.2.2. Kits

8.2.2.1.Y-o-Y Growth Comparison

8.2.2.2.Market Value Forecast

8.2.2.3.Pure-Platelet Rich Plasma (P-PRP) Kits Sub-segment

8.2.2.3.1.Y-o-Y Growth Comparison

8.2.2.3.2.Market Value Forecast

8.2.2.4.Leukocyte-rich Platelet-rich Plasma (L-PRP) Kits Sub-segment

8.2.2.4.1.Y-o-Y Growth Comparison

8.2.2.4.2.Market Value Forecast

8.2.2.5.Leukocyte-Platelet-rich Fibrin (L-PRF) Kits Sub-segment

8.2.2.5.1.Y-o-Y Growth Comparison

8.2.2.5.2.Market Value Forecast

8.2.2.6.Pure- Platelet-rich Fibrin (P-PRF) Kits Sub-segment

8.2.2.6.1.Y-o-Y Growth Comparison

8.2.2.6.2.Market Value Forecast

8.2.2.7.Autologous Platelet-rich Plasma Kits Sub-segment

8.2.2.7.1.Y-o-Y Growth Comparison

8.2.2.7.2.Market Value Forecast

8.2.2.8.Homologous Platelet-rich Plasma Kits Sub-segment

8.2.2.8.1.Y-o-Y Growth Comparison

8.2.2.8.2.Market Value Forecast

8.2.2.9.Allogeneic Platelet-rich Plasma Kits Sub-segment

8.2.2.9.1.Y-o-Y Growth Comparison

8.2.2.9.2.Market Value Forecast

8.2.3.Europe PRP Market Attractiveness Analysis, by Product Type, 2014–2024

8.3.Europe Platelet-rich Plasma (PRP) Market Revenue, by Application, 2013–2024

8.3.1. Introduction

8.3.1.1.Europe PRP Market Value Share & BPS Analysis, by Application, 2014 & 2024

8.3.1.2.Europe PRP Market Y-o-Y Growth Comparison, by Application, 2013–2024

8.4.Market Value Forecast, By Application

8.4.1. Knee

8.4.1.1.Y-o-Y Growth Comparison

8.4.1.2.Market Value Forecast

8.4.2. Elbow 

8.4.2.1.Y-o-Y Growth Comparison

8.4.2.2.Market Value Forecast

8.4.3. Foot and Ankle 

8.4.3.1.Y-o-Y Growth Comparison

8.4.3.2.Market Value Forecast

8.4.4. Shoulder

8.4.4.1.Y-o-Y Growth Comparison

8.4.4.2.Market Value Forecast

8.4.5. CMF

8.4.5.1.Y-o-Y Growth Comparison

8.4.5.2.Market Value Forecast

8.4.6. Other

8.4.6.1.Y-o-Y Growth Comparison

8.4.6.2.Market Value Forecast

8.4.7.Europe PRP Market Attractiveness Analysis, by Application, 2014–2024

8.5.Europe Platelet-rich Plasma (PRP) Market Revenue, by Country, 2013–2024

8.5.1. Introduction

8.5.1.1.Europe PRP Market Value Share & BPS Analysis, by Country, 2014 & 2024

8.5.1.2.Europe PRP Market Y-o-Y Growth Comparison, by Country, 2013–2024

8.6.Market Value Forecast, By Country

8.6.1. Germany

8.6.1.1.Y-o-Y Growth Comparison

8.6.1.2.Market Value Forecast

8.6.2. France 

8.6.2.1.Y-o-Y Growth Comparison

8.4.3.2.Market Value Forecast

8.6.3. U.K.

8.6.3.1.Y-o-Y Growth Comparison

8.6.3.2.Market Value Forecast

8.6.4. Italy 

8.6.4.1.Y-o-Y Growth Comparison

8.6.4.2.Market Value Forecast

8.6.5. Spain

8.6.5.1.Y-o-Y Growth Comparison

8.6.5.2.Market Value Forecast

8.6.6. Rest of Europe 

8.6.6.1.Y-o-Y Growth Comparison

8.6.6.2.Market Value Forecast

8.7.Europe PRP Market Attractiveness Analysis, by Country, 2014–2024

9.Competitive Landscape

9.1.Competition Dashboard

9.2.Company Profiles

9.2.1.Arthrex, Inc.

9.2.2.Stryker Corporation

9.2.3.Johnson and Johnsons Ltd

9.2.4.Zimmer Biomet Holdings Inc.

9.2.5. Terumo Corporation

9.2.6. Glofinn Oy

9.2.7. Medira Ltd.

9.2.8.Regen Lab S.A.

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Europe PRP Market Value, by Product Type, US$ Mn, 2013–2024

Table 2: Europe PRP Market Value, by Application, US$ Mn, 2013–2024

Table 3: Europe PRP Market Value, by Country, US$ Mn, 2013–2024

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 2: Europe PRP Market Value Share & BPS Analysis, by Product Type, 2014 & 2024

Figure 3: Europe PRP Market Y-o-Y Growth Comparison, by Product Type, 2013–2024

Figure 4: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Instruments Segment, 2013–2024

Figure 5: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Kits Segment, 2013–2024

Figure 6: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Pure Platelet-rich Plasma (P-PRP) Kits Sub-segment, 2013–2024

Figure 7: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Leukocyte-rich Platelet-rich Plasma (L-PRP) Kits Sub-segment, 2013–2024

Figure 8: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Leukocyte-Platelet-rich Fibrin (L-PRF) Kits Sub-segment, 2013–2024

Figure 9: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Pure Platelet-rich Fibrin (P-PRF) Kits Sub-segment, 2013–2024

Figure 10: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Autologous Platelet-rich Plasma Kits Sub-segment, 2013–2024

Figure 11: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Homologous Platelet-rich Plasma Kits Sub-segment, 2013–2024

Figure 12: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Allogeneic Platelet-rich Plasma Kits Sub-segment, 2013–2024

Figure 13: Europe PRP Market Attractiveness Analysis, by Product Type, 2014–2024

Figure 14: Europe PRP Market Value Share & BPS Analysis, by Application, 2014 & 2024

Figure 15: Europe PRP Market Y-o-Y Growth Comparison, by Application, 2013–2024

Figure 16: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Knee Segment, 2013–2024

Figure 17: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Elbow Segment, 2013–2024

Figure 18: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Foot and Ankle Segment, 2013–2024

Figure 19 Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Shoulder Segment, 2013–2024

Figure 20: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by CMF Segment, 2013–2024

Figure 21: Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), by Others Segment, 2013–2024

Figure 22: Europe PRP Market Attractiveness Analysis by Application Type, 2014–2024

Figure 23: Europe PRP Market Value Share & BPS Analysis, by Country, 2014 & 2024

Figure 24: Europe PRP Market Y-o-Y Growth Comparison, by Country, 2013–2024

Figure 25: Germany PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 26: France PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 27: U.K. PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 28: Italy PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 29: Spain PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 30: Rest of Europe PRP Market Value (US$ Mn) & Y-o-Y Growth (%), 2013–2024

Figure 31: Europe PRP Market Attractiveness Analysis, by Country Type, 2014–2024

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Europe Platelet Rich Plasma (PRP) Market